Ridgeview

Recent papers from Ridgeview

1. Identification of a Shiga toxin A‐derived peptide internalized into Gb3 receptor‐bearing cells via interaction with the Shiga toxin B subunitFEBS Letters · 2026
2. Deciphering the RNA recognition by Musashi-1 to design protein and RNA variants for in vitro and in vivo applicationsNucleic Acids Research · 2025
3. Deciphering the RNA recognition by Musashi-1 to design protein and RNA mutants for in vitro and in vivo applications2024
4. Impact of site-specific conjugation strategies on the pharmacokinetics of antibody conjugated radiotherapeuticsEuropean Journal of Medicinal Chemistry · 2024
5. Patient-Reported and Economic Racial and Ethnic Disparities in Patients with Psoriatic Arthritis: Results from the National Health and Wellness SurveyRheumatology and Therapy · 2024
6. Clinicians’ Preferences for Sphingosine-1-Phosphate Receptor Modulators in Multiple Sclerosis Based on Clinical Management Considerations: A Choice ExperimentPharmacoEconomics - Open · 2024
7. Crude Oil Price Movements and Institutional TradersCommodities · 2024
8. Repurposing the mammalian RNA-binding protein Musashi-1 as an allosteric translation repressor in bacteriaeLife · 2024
9. Repurposing the mammalian RNA-binding protein Musashi-1 as an allosteric translation repressor in bacteriaeLife · 2024
10. Repurposing the mammalian RNA-binding protein Musashi-1 as an allosteric translation repressor in bacteriaeLife · 2023
11. Repurposing the mammalian RNA-binding protein Musashi-1 as an allosteric translation repressor in bacteriaeLife · 2023
12. Multivalent design of the monoclonal SynO2 antibody improves binding strength to soluble α-Synuclein aggregatesmAbs · 2023
13. Modelling ligand depletion for simultaneous affinity and binding site quantification on cells and tissueScientific Reports · 2023
14. Effect of Intravenous Golimumab on Fatigue and the Relationship with Clinical Response in Adults with Active Ankylosing Spondylitis in the Phase 3 GO-ALIVE StudyRheumatology and Therapy · 2023
15. Patient Perceptions of CAR-T Therapy in the USA: Findings from In-Depth InterviewsOncology and Therapy · 2023
16. Real-World Effectiveness of 9–12 Months of Guselkumab Therapy among Patients with Moderate-to-Severe Plaque Psoriasis in the CorEvitas Psoriasis RegistryDermatology and Therapy · 2022
17. Racial or ethnic differences on treatment adherence and persistence among patients with inflammatory bowel diseases initiated with biologic therapiesBMC Gastroenterology · 2022
18. Amivantamab, an Epidermal Growth Factor Receptor (EGFR) and Mesenchymal-epithelial Transition Factor (MET) Bispecific Antibody, Designed to Enable Multiple Mechanisms of Action and Broad Clinical ApplicationsClinical Lung Cancer · 2022
19. Real-world patient characteristics and treatment outcomes among nontransplanted multiple myeloma patients who received Bortezomib in combination with Lenalidomide and Dexamethasone as first line of therapy in the United StatesBMC Cancer · 2022
20. Concept of the Number Needed to Treat for the Analysis of Pain Relief Outcomes in Patients Treated with Spinal Cord StimulationBiomedicines · 2022